Loading company…
Magenta Therapeutics, Inc. is a Cambridge, US biotech developing stem cell-based therapies for serious diseases.
Founded in 2015 and headquartered in Cambridge, US, Magenta Therapeutics, Inc. develops cellular therapies that use stem cells to treat serious diseases, with a focus on transplant medicine. The company has raised USD 86.40 mn across multiple rounds, most recently a PIPE in June 2020 with investors including Deep Track Capital and OrbiMed Advisors. It raised USD 100 million in an IPO in June 2018, and Jason Gardner is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in